推荐论文 | 长新冠高压氧治疗综述

已有 611 次阅读 2024-2-23 22:32 |个人分类:CMS推荐论文|系统分类:论文交流

Hyperbaric Oxygen Treatment for Long COVID: From Molecular Mechanism to Clinical Practice

作者:Jian-qing Pan, Zhi-min Tian & Lian-bi Xue

Pan, Jq., Tian, Zm. & Xue, Lb. Hyperbaric Oxygen Treatment for Long COVID: From Molecular Mechanism to Clinical Practice. CURR MED SCI 43, 1061–1065 (2023).



Long COVID symptoms typically occur within 3 months of an initial COVID-19 infection, last for more than 2 months, and cannot be explained by other diagnoses. The most common symptoms include fatigue, dyspnea, coughing, and cognitive impairment. The mechanisms of long COVID are not fully understood, but several hypotheses have been put forth. These include coagulation and fibrosis pathway activation, inflammatory and autoimmune manifestations, persistent virus presence, and Epstein-Barr virus reactivation. Hyperbaric oxygen therapy (HBOT) is a therapeutic method in which a person inhales 100% oxygen under pressure greater than that of the atmosphere. HBOT has some therapeutic effects, including improvement of microcirculation, inhibition of cytokine release leading to a reduction in inflammatory responses, inhibition of autoimmune responses, and promotion of neurological repair. Several clinical trials have been carried out using HBOT to treat long COVID. The results suggest that HBOT helps to improve symptom severity, reduce symptom duration, and enhance patients’ quality of life. It is believed that HBOT is an effective option for patients with long COVID, which is worth actively promoting.

上一篇:推荐论文 | POLE2通过PI3K/AKT信号通路调控口腔鳞状细胞癌细胞凋亡
下一篇:推荐论文 | 2022年WHO垂体肿瘤分类修订解读
收藏 IP: 117.135.23.*| 热度|


该博文允许注册用户评论 请点击登录 评论 (0 个评论)


Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-5-19 17:19

Powered by

Copyright © 2007- 中国科学报社